Golestan University of Medical Sciences Repository

Items where Author is "Lotfinia, M."

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Jump to: Article
Number of items: 13.

Article

Abdollahpour-Alitappeh, M. and Lotfinia, M. and Gharibi, T. and Mardaneh, J. and Farhadihosseinabadi, B. and Larki, P. and Faghfourian, B. and Sepehr, K.S. and Abbaszadeh-Goudarzi, K. and Abbaszadeh-Goudarzi, G. and Johari, B. and Zali, M.R. and Bagheri, N. (2019) Antibody�drug conjugates (ADCs) for cancer therapy: Strategies, challenges, and successes. Journal of Cellular Physiology, 234 (5). pp. 5628-5642.

Abdollahpour-Alitappeh, M. and Lotfinia, M. and Gharibi, T. and Mardaneh, J. and Farhadihosseinabadi, B. and Larki, P. and Faghfourian, B. and Sepehr, K.S. and Abbaszadeh-Goudarzi, K. and Abbaszadeh-Goudarzi, G. and Johari, B. and Zali, M.R. and Bagheri, N. (2019) Antibody�drug conjugates (ADCs) for cancer therapy: Strategies, challenges, and successes. Journal of Cellular Physiology, 234 (5). pp. 5628-5642.

Abdollahpour-Alitappeh, M. and Lotfinia, M. and Gharibi, T. and Mardaneh, J. and Farhadihosseinabadi, B. and Larki, P. and Faghfourian, B. and Sepehr, K.S. and Abbaszadeh-Goudarzi, K. and Abbaszadeh-Goudarzi, G. and Johari, B. and Zali, M.R. and Bagheri, N. (2019) Antibody�drug conjugates (ADCs) for cancer therapy: Strategies, challenges, and successes. Journal of Cellular Physiology, 234 (5). pp. 5628-5642.

Abdollahpour-Alitappeh, M. and Lotfinia, M. and Gharibi, T. and Mardaneh, J. and Farhadihosseinabadi, B. and Larki, P. and Faghfourian, B. and Sepehr, K.S. and Abbaszadeh-Goudarzi, K. and Abbaszadeh-Goudarzi, G. and Johari, B. and Zali, M.R. and Bagheri, N. (2019) Antibody�drug conjugates (ADCs) for cancer therapy: Strategies, challenges, and successes. Journal of Cellular Physiology, 234 (5). pp. 5628-5642.

Abdollahpour-Alitappeh, M. and Lotfinia, M. and Gharibi, T. and Mardaneh, J. and Farhadihosseinabadi, B. and Larki, P. and Faghfourian, B. and Sepehr, K.S. and Abbaszadeh-Goudarzi, K. and Abbaszadeh-Goudarzi, G. and Johari, B. and Zali, M.R. and Bagheri, N. (2019) Antibody�drug conjugates (ADCs) for cancer therapy: Strategies, challenges, and successes. Journal of Cellular Physiology, 234 (5). pp. 5628-5642.

Abdollahpour-Alitappeh, M. and Lotfinia, M. and Bagheri, N. and Sineh Sepehr, K. and Habibi-Anbouhi, M. and Kobarfard, F. and Balalaie, S. and Foroumadi, A. and Abbaszadeh-Goudarzi, G. and Abbaszadeh-Goudarzi, K. and Abolhassani, M. (2019) Trastuzumab-monomethyl auristatin E conjugate exhibits potent cytotoxic activity in vitro against HER2-positive human breast cancer. Journal of Cellular Physiology, 234 (3). pp. 2693-2704.

Abdollahpour-Alitappeh, M. and Lotfinia, M. and Bagheri, N. and Sineh Sepehr, K. and Habibi-Anbouhi, M. and Kobarfard, F. and Balalaie, S. and Foroumadi, A. and Abbaszadeh-Goudarzi, G. and Abbaszadeh-Goudarzi, K. and Abolhassani, M. (2019) Trastuzumab-monomethyl auristatin E conjugate exhibits potent cytotoxic activity in vitro against HER2-positive human breast cancer. Journal of Cellular Physiology, 234 (3). pp. 2693-2704.

Abdollahpour-Alitappeh, M. and Lotfinia, M. and Bagheri, N. and Sineh Sepehr, K. and Habibi-Anbouhi, M. and Kobarfard, F. and Balalaie, S. and Foroumadi, A. and Abbaszadeh-Goudarzi, G. and Abbaszadeh-Goudarzi, K. and Abolhassani, M. (2019) Trastuzumab-monomethyl auristatin E conjugate exhibits potent cytotoxic activity in vitro against HER2-positive human breast cancer. Journal of Cellular Physiology, 234 (3). pp. 2693-2704.

Abdollahpour-Alitappeh, M. and Lotfinia, M. and Bagheri, N. and Sineh Sepehr, K. and Habibi-Anbouhi, M. and Kobarfard, F. and Balalaie, S. and Foroumadi, A. and Abbaszadeh-Goudarzi, G. and Abbaszadeh-Goudarzi, K. and Abolhassani, M. (2019) Trastuzumab-monomethyl auristatin E conjugate exhibits potent cytotoxic activity in vitro against HER2-positive human breast cancer. Journal of Cellular Physiology, 234 (3). pp. 2693-2704.

Abdollahpour-Alitappeh, M. and Lotfinia, M. and Bagheri, N. and Sineh Sepehr, K. and Habibi-Anbouhi, M. and Kobarfard, F. and Balalaie, S. and Foroumadi, A. and Abbaszadeh-Goudarzi, G. and Abbaszadeh-Goudarzi, K. and Abolhassani, M. (2019) Trastuzumab-monomethyl auristatin E conjugate exhibits potent cytotoxic activity in vitro against HER2-positive human breast cancer. Journal of Cellular Physiology, 234 (3). pp. 2693-2704.

Abdollahpour-Alitappeh, M. and Lotfinia, M. and Gharibi, T. and Mardaneh, J. and Farhadihosseinabadi, B. and Larki, P. and Faghfourian, B. and Sepehr, K.S. and Abbaszadeh-Goudarzi, K. and Abbaszadeh-Goudarzi, G. and Johari, B. and Zali, M.R. and Bagheri, N. (2018) Antibody–drug conjugates (ADCs) for cancer therapy: Strategies, challenges, and successes. Journal of Cellular Physiology.

Abdollahpour-Alitappeh, M. and Lotfinia, M. and Bagheri, N. and Sineh Sepehr, K. and Habibi-Anbouhi, M. and Kobarfard, F. and Balalaie, S. and Foroumadi, A. and Abbaszadeh-Goudarzi, G. and Abbaszadeh-Goudarzi, K. and Abolhassani, M. (2018) Trastuzumab-monomethyl auristatin E conjugate exhibits potent cytotoxic activity in vitro against HER2-positive human breast cancer. Journal of Cellular Physiology.

Ghaemi, A. and Sajadian, A. and Khodaie, B. and Lotfinia, A.A. and Lotfinia, M. and Aghabarari, A. and Khaleghi Ghadiri, M. and Meuth, S. and Gorji, A. (2016) Immunomodulatory Effect of Toll-Like Receptor-3 Ligand Poly I:C on Cortical Spreading Depression. Molecular Neurobiology, 53 (1). pp. 143-154. ISSN 15591182

This list was generated on Mon Aug 19 07:29:15 2019 IRDT.